- Home
- SRM vs AIMD Comparison
SRM vs AIMD Comparison
Compare SRM & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- AIMD
- Stock Information
- Founded
- SRM 1979
- AIMD 1984
- Country
- SRM United States
- AIMD United States
- Employees
- SRM N/A
- AIMD N/A
- Industry
- SRM
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- AIMD Health Care
- Exchange
- SRM Nasdaq
- AIMD Nasdaq
- Market Cap
- SRM 9.0M
- AIMD 8.2M
- IPO Year
- SRM 2023
- AIMD N/A
- Fundamental
- Price
- SRM $7.75
- AIMD $0.51
- Analyst Decision
- SRM
- AIMD
- Analyst Count
- SRM 0
- AIMD 0
- Target Price
- SRM N/A
- AIMD N/A
- AVG Volume (30 Days)
- SRM 20.0M
- AIMD 262.5K
- Earning Date
- SRM 08-11-2025
- AIMD 08-04-2025
- Dividend Yield
- SRM N/A
- AIMD N/A
- EPS Growth
- SRM N/A
- AIMD N/A
- EPS
- SRM N/A
- AIMD N/A
- Revenue
- SRM $4,394,659.00
- AIMD $106,207.00
- Revenue This Year
- SRM N/A
- AIMD N/A
- Revenue Next Year
- SRM N/A
- AIMD N/A
- P/E Ratio
- SRM N/A
- AIMD N/A
- Revenue Growth
- SRM N/A
- AIMD 13.38
- 52 Week Low
- SRM $0.26
- AIMD $0.40
- 52 Week High
- SRM $12.80
- AIMD $1.07
- Technical
- Relative Strength Index (RSI)
- SRM 65.73
- AIMD 38.36
- Support Level
- SRM $7.20
- AIMD $0.49
- Resistance Level
- SRM $12.80
- AIMD $0.52
- Average True Range (ATR)
- SRM 1.68
- AIMD 0.05
- MACD
- SRM 0.53
- AIMD -0.01
- Stochastic Oscillator
- SRM 59.80
- AIMD 12.55
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.